<br>
<br>"(4) Biennial report.—Not later than 1 year after the date of enactment of the PREEMIE Reauthorization Act of 2018 [Dec. 18, 2018], and every 2 years thereafter, the Advisory Committee shall—
<br>
<br>"(A) publish a report summarizing activities and recommendations of the Advisory Committee since the publication of the previous report;
<br>
<br>"(B) submit such report to the Secretary and the appropriate Committees of Congress; and
<br>
<br>"(C) post such report on the Internet website of the Department of Health and Human Services."
<br>Purpose
<br>
<br>Pub. L. 109–450, §2, Dec. 22, 2006, 120 Stat. 3341, provided that: "It is the purpose of this Act [enacting this section and sections 247b–4g and 280g–5 of this title and amending sections 241 and 280g–4 of this title] to—
<br>
<br>"(1) reduce rates of preterm labor and delivery;
<br>
<br>"(2) work toward an evidence-based standard of care for pregnant women at risk of preterm labor or other serious complications, and for infants born preterm and at a low birthweight; and
<br>
<br>"(3) reduce infant mortality and disabilities caused by prematurity."
<br>
<br>1 So in original.
<br>§247b–4g. Repealed. Pub. L. 113–55, title I, §104(a), Nov. 27, 2013, 127 Stat. 643
<br>
<br>Section, Pub. L. 109–450, §5, Dec. 22, 2006, 120 Stat. 3343, related to establishment and activities of the Interagency Coordinating Council on Prematurity and Low Birthweight.
<br>§247b–5. Preventive health measures with respect to prostate cancer
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States and local health departments for the purpose of enabling such States and departments to carry out programs that may include the following:
<br>
<br>(1) To identify factors that influence the attitudes or levels of awareness of men and health care practitioners regarding screening for prostate cancer.
<br>
<br>(2) To evaluate, in consultation with the Agency for Health Care Policy and Research and the National Institutes of Health, the effectiveness of screening strategies for prostate cancer.
<br>
<br>(3) To identify, in consultation with the Agency for Health Care Policy and Research, issues related to the quality of life for men after prostrate 1 cancer screening and followup.
<br>
<br>(4) To develop and disseminate public information and education programs for prostate cancer, including appropriate messages about the risks and benefits of prostate cancer screening for the general public, health care providers, policy makers and other appropriate individuals.
<br>
<br>(5) To improve surveillance for prostate cancer.
<br>
<br>(6) To address the needs of underserved and minority populations regarding prostate cancer.
<br>
<br>(7) Upon a determination by the Secretary, who shall take into consideration recommendations by the United States Preventive Services Task Force and shall seek input, where appropriate, from professional societies and other private and public entities, that there is sufficient consensus on the effectiveness of prostate cancer screening—
<br>
<br>(A) to screen men for prostate cancer as a preventive health measure;
<br>
<br>(B) to provide appropriate referrals for the medical treatment of men who have been screened under subparagraph (A) and to ensure, to the extent practicable, the provision of appropriate followup services and support services such as case management;
<br>
<br>(C) to establish mechanisms through which State and local health departments can monitor the quality of screening procedures for prostate cancer, including the interpretation of such procedures; and
<br>
<br>(D) to improve, in consultation with the Health Resources and Services Administration, the education, training, and skills of health practitioners (including appropriate allied health professionals) in the detection and control of prostate cancer.
<br>
<br>(8) To evaluate activities conducted under paragraphs (1) through (7) through appropriate surveillance or program monitoring activities.
<br>(b) Requirement of matching funds
<br>(1) In general
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees, with respect to the costs to be incurred by the applicant in carrying out the purpose described in such section, to make available non-Federal contributions (in cash or in kind under paragraph (2)) toward such costs in an amount equal to not less than $1 for each $3 of Federal funds provided in the grant. Such contributions may be made directly or through donations from public or private entities.
<br>(2) Determination of amount of non-Federal contribution
<br>
<br>(A) Non-Federal contributions required in paragraph (1) may be in cash or in kind, fairly evaluated, including equipment or services (and excluding indirect or overhead costs). Amounts provided by the Federal Government, or services assisted or subsidized to any significant extent by the Federal Government, may not be included in determining the amount of such non-Federal contributions.
<br>
<br>(B) In making a determination of the amount of non-Federal contributions for purposes of paragraph (1), the Secretary may include only non-Federal contributions in excess of the average amount of non-Federal contributions made by the applicant involved toward the purpose described in subsection (a) for the 2-year period preceding the fiscal year for which the applicant involved is applying to receive a grant under such subsection.
<br>
<br>(C) In making a determination of the amount of non-Federal contributions for purposes of paragraph (1), the Secretary shall, subject to subparagraphs (A) and (B) of this paragraph, include any non-Federal amounts expended pursuant to title XIX of the Social Security Act [42 U.S.C. 1396 et seq.] by the applicant involved toward the purpose described in paragraphs (1) and (2) of subsection (a).
<br>(c) Education on significance of early detection
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that, in carrying out subsection (a)(3), the applicant will carry out education programs to communicate to men, and to local health officials, the significance of the early detection of prostate cancer.
<br>(d) Requirement of provision of all services by date certain
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees—
<br>
<br>(1) to ensure that, initially and throughout the period during which amounts are received pursuant to the grant, not less than 60 percent of the grant is expended to provide each of the services or activities described in paragraphs (1) and (2) of such subsection;
<br>
<br>(2) to ensure that, by the end of any second fiscal year of payments pursuant to the grant, each of the services or activities described in such subsection is provided; and
<br>
<br>(3) to ensure that not more than 40 percent of the grant is expended to provide the services or activities described in paragraphs (3) through (6) of such section.2
<br>(e) Additional required agreements
<br>(1) Priority for low-income men
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that low-income men, and men at risk of prostate cancer, will be given priority in the provision of services and activities pursuant to paragraphs (1) and (2) of such subsection.
<br>(2) Limitation on imposition of fees for services
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that, if a charge is imposed for the provision of services or activities under the grant, such charge—
<br>
<br>(A) will be made according to a schedule of charges that is made available to the public;
<br>
<br>(B) will be adjusted to reflect the income of the man involved; and
<br>
<br>(C) will not be imposed on any man with an income of less than 100 percent of the official poverty line, as established by the Director of the Office of Management and Budget and revised by the Secretary in accordance with section 9902(2) of this title.
<br>(3) Relationship to items and services under other programs
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that the grant will not be expended to make payment for any item or service to the extent that payment has been made, or can reasonably be expected to be made, with respect to such item or service—
<br>
<br>(A) under any State compensation program, under an insurance policy, or under any Federal or State health benefits program; or
<br>
<br>(B) by an entity that provides health services on a prepaid basis.
<br>(4) Coordination with other prostate cancer programs
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that the services and activities funded through the grant will be coordinated with other Federal, State, and local prostate cancer programs.
<br>(5) Limitation on administrative expenses
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that not more than 10 percent of the grant will be expended for administrative expenses with respect to the grant.
<br>(6) Restrictions on use of grant
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that the grant will not be expended to provide inpatient hospital services for any individual.
<br>(7) Records and audits
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees that—
<br>
<br>(A) the applicant will establish such fiscal control and fund accounting procedures as may be necessary to ensure the proper disbursal of, and accounting for, amounts received by the applicant under such section; 3 and
<br>
<br>(B) upon request, the applicant will provide records maintained pursuant to paragraph (1) to the Secretary or the Comptroller of the United States for purposes of auditing the expenditures by the applicant of the grant.
<br>(f) Reports to Secretary
<br>
<br>The Secretary may not make a grant under subsection (a) unless the applicant involved agrees to submit to the Secretary such reports as the Secretary may require with respect to the grant.
<br>(g) Description of intended uses of grant
<br>
<br>The Secretary may not make a grant under subsection (a) unless—
<br>
<br>(1) the applicant involved submits to the Secretary a description of the purposes for which the applicant intends to expend the grant;
<br>
<br>(2) the description identifies the populations, areas, and localities in the applicant 4 with a need for the services or activities described in subsection (a);
<br>
<br>(3) the description provides information relating to the services and activities to be provided, including a description of the manner in which the services and activities will be coordinated with any similar services or activities of public or nonprivate entities; and
<br>
<br>(4) the description provides assurances that the grant funds will be used in the most cost-effective manner.
<br>(h) Requirement of submission of application
<br>
<br>The Secretary may not make a grant under subsection (a) unless an application for the grant is submitted to the Secretary, the application contains the description of intended uses required in subsection (g), and the application is in such form, is made in such manner, and contains such agreements, assurances, and information as the Secretary determines to be necessary to carry out this section.
<br>(i) Method and amount of payment
<br>
<br>The Secretary shall determine the amount of a grant made under subsection (a). Payments under such grants may be made in advance on the basis of estimates or by way of reimbursement, with necessary adjustments on account of the underpayments or overpayments, and in such installments and on such terms and conditions as the Secretary finds necessary to carry out the purposes of such grants.
<br>(j) Technical assistance and provision of supplies and services in lieu of grant funds
<br>(1) Technical assistance
<br>
<br>The Secretary may provide training and technical assistance with respect to the planning, development, and operation of any program or service carried out pursuant to subsection (a). The Secretary may provide such technical assistance directly or through grants to, or contracts with, public and private entities.
<br>(2) Provision of supplies and services in lieu of grant funds
<br>
<br>(A) Upon the request of an applicant receiving a grant under subsection (a), the Secretary may, subject to subparagraph (B), provide supplies, equipment, and services for the purpose of aiding the applicant in carrying out such section and, for such purpose, may detail to the applicant any officer or employee of the Department of Health and Human Services.
<br>
<br>(B) With respect to a request described in subparagraph (A), the Secretary shall reduce the amount of payments under the grant under subsection (a) to the applicant involved by an amount equal to the costs of detailing personnel (including pay, allowances, and travel expenses) and the fair market value of any supplies, equipment, or services provided by the Secretary. The Secretary shall, for the payment of expenses incurred in complying with such request, expend the amounts withheld.
<br>(k) "Units of local government" defined
<br>
<br>For purposes of this section, the term "units of local government" includes Indian tribes.
<br>(l) Authorization of appropriations
<br>(1) In general
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated $20,000,000 for fiscal year 1993, and such sums as may be necessary for each of the fiscal years 1994 through 2004.
<br>(2) Allocation for technical assistance
<br>
<br>Of the amounts appropriated under paragraph (1) for a fiscal year, the Secretary shall reserve not more than 20 percent for carrying out subsection (j)(1).
<br>
<br>(July 1, 1944, ch. 373, title III, §317D, as added Pub. L. 102–531, title III, §308, Oct. 27, 1992, 106 Stat. 3495; amended Pub. L. 103–43, title XX, §2010(i)(1)(B)(iv), June 10, 1993, 107 Stat. 213; Pub. L. 103–183, title VII, §705(b), Dec. 14, 1993, 107 Stat. 2241; Pub. L. 105–392, title IV, §401(a)(3), Nov. 13, 1998, 112 Stat. 3587; Pub. L. 106–505, title VI, §602(a), Nov. 13, 2000, 114 Stat. 2345.)
<br>References in Text
<br>
<br>The Social Security Act, referred to in subsec. (b)(2)(C), is act Aug. 14, 1935, ch. 531, 49 Stat. 620, as amended. Title XIX of the Act is classified generally to subchapter XIX (§1396 et seq.) of chapter 7 of this title. For complete classification of this Act to the Code, see section 1305 of this title and Tables.
<br>Amendments
<br>
<br>2000—Subsec. (a). Pub. L. 106–505, §602(a)(1), added subsec. (a) and struck out heading and text of former subsec. (a). Text read as follows: "The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States and local health departments for the purpose of enabling such States and departments to carry out programs—
<br>
<br>"(1) to screen men for prostate cancer as a preventive health measure;
<br>
<br>"(2) to provide appropriate referrals for medical treatment of men screened pursuant to paragraph (1) and to ensure, to the extent practicable, the provision of appropriate follow-up services;
<br>
<br>"(3) to develop and disseminate public information and education programs for the detection and control of prostate cancer;
<br>
<br>"(4) to improve the education, training, and skills of health professionals (including appropriate allied health professionals) in the detection and control of prostate cancer;
<br>
<br>"(5) to establish mechanisms through which the States and such departments can monitor the quality of screening procedures for prostate cancer, including the interpretation of such procedures; and
<br>
<br>"(6) to evaluate activities conducted under paragraphs (1) through (5) through appropriate surveillance or program monitoring activities."
<br>
<br>Subsec. (l)(1). Pub. L. 106–505, §602(a)(2), substituted "2004" for "1998".
<br>
<br>1998—Subsec. (l)(1). Pub. L. 105–392 made technical amendment to directory language of Pub. L. 103–183. See 1993 Amendment note below.
<br>
<br>1993—Pub. L. 103–43 made technical amendment to directory language of Pub. L. 102–531, §308, which enacted this section.
<br>
<br>Subsec. (l)(1). Pub. L. 103–183, as amended by Pub. L. 105–392, substituted "through 1998" for "through 1996".
<br>Effective Date of 1998 Amendment
<br>
<br>Amendment by Pub. L. 105–392 deemed to have taken effect immediately after enactment of Pub. L. 103–183, see section 401(e) of Pub. L. 105–392, set out as a note under section 242m of this title.
<br>
<br>1 So in original. Probably should be "prostate".
<br>
<br>2 So in original. Probably should be "subsection."
<br>
<br>3 So in original. Probably should be "subsection;".
<br>
<br>4 So in original. Probably should be "application".
<br>§247b–6. National strategy for combating and eliminating tuberculosis
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States, political subdivisions, and other public entities for preventive health service programs for the prevention, control, and elimination of tuberculosis.
<br>(b) Research and development; demonstration projects; education and training
<br>
<br>With respect to the prevention, treatment, control, and elimination of tuberculosis, the Secretary may, directly or through grants to public or nonprofit private entities, carry out the following:
<br>
<br>(1) Research, with priority given to research and development concerning latent tuberculosis infection, strains of tuberculosis resistant to drugs, and research concerning cases of tuberculosis that affect certain populations at risk for tuberculosis.
<br>
<br>(2) Research and development and related activities to develop new tools for the elimination of tuberculosis, including drugs, diagnostics, vaccines, and public health interventions, such as directly observed therapy and non-pharmaceutical intervention, and methods to enhance detection and response to outbreaks of tuberculosis, including multidrug resistant tuberculosis. The Secretary is encouraged to give priority to programmatically relevant research so that new tools can be utilized in public health practice.
<br>
<br>(3) Demonstration projects for—
<br>
<br>(A) the development of regional capabilities to prevent, control, and eliminate tuberculosis and prevent multidrug resistant and extensively drug resistant strains of tuberculosis;
<br>
<br>(B) the intensification of efforts to reduce health disparities in the incidence of tuberculosis;
<br>
<br>(C) the intensification of efforts to control tuberculosis along the United States-Mexico border and among United States-Mexico binational populations, including through expansion of the scope and number of programs that—
<br>
<br>(i) detect and treat binational cases of tuberculosis; and
<br>
<br>(ii) treat high-risk cases of tuberculosis referred from Mexican health departments;
<br>
<br>(D) the intensification of efforts to prevent, detect, and treat tuberculosis among foreign-born persons who are in the United States;
<br>
<br>(E) the intensification of efforts to prevent, detect, and treat tuberculosis among populations and settings documented as having a high risk for tuberculosis; and
<br>
<br>(F) tuberculosis detection, control, and prevention.
<br>
<br>(4) Public information and education activities.
<br>
<br>(5) Education, training, clinical skills improvement activities, and workplace exposure prevention for health professionals, including allied health personnel and emergency response employees.
<br>
<br>(6) Support of Centers to carry out activities under paragraphs (1) through (4).
<br>
<br>(7) Collaboration with international organizations and foreign countries in carrying out such activities.
<br>
<br>(8) Develop, enhance, and expand information technologies that support tuberculosis control including surveillance and database management systems with cross-jurisdictional capabilities, which shall conform to the standards and implementation specifications for such information technologies as recommended by the Secretary.
<br>(c) Cooperation with providers of primary health services
<br>
<br>The Secretary may make a grant under subsection (a) or (b) only if the applicant for the grant agrees that, in carrying out activities under the grant, the applicant will cooperate with public and nonprofit private providers of primary health services or substance abuse services, including entities receiving assistance under section 254b, 254b, or 256a of this title 1 or under subchapter III–A or XVII.
<br>(d) Application for grant
<br>(1) In general
<br>
<br>The Secretary may make a grant under subsection (a) or (b) only if an application for the grant is submitted to the Secretary and the application, subject to paragraph (2), is in such form, is made in such manner, and contains such agreements, assurances, and information as the Secretary determines to be necessary to carry out the subsection involved.
<br>(2) Plan for prevention, control, and elimination
<br>
<br>The Secretary may make a grant under subsection (a) only if the application under paragraph (1) contains a plan regarding the prevention, control, and elimination of tuberculosis in the geographic area with respect to which the grant is sought.
<br>(3) Determination of amount of nonfederal contributions
<br>(A) Priority
<br>
<br>In awarding grants under subsection (a) or (b), the Secretary shall give highest priority to an applicant that provides assurances that the applicant will contribute non-Federal funds to carry out activities under this section, which may be provided directly or through donations from public or private entities and may be in cash or in kind, including equipment or services.
<br>(B) Federal amounts not to be included as contributions
<br>
<br>Amounts provided by the Federal Government, or services assisted or subsidized to any significant extent by the Federal Government, may not be included in determining the amount of non-Federal contributions as described in subparagraph (A).
<br>(e) Supplies and services in lieu of grant funds
<br>(1) In general
<br>
<br>Upon the request of a grantee under subsection (a) or (b), the Secretary may, subject to paragraph (2), provide supplies, equipment, and services for the purpose of aiding the grantee in carrying out the subsection involved and, for such purpose, may detail to the State any officer or employee of the Department of Health and Human Services.
<br>(2) Corresponding reduction in payments
<br>
<br>With respect to a request described in paragraph (1), the Secretary shall reduce the amount of payments under the grant involved by an amount equal to the costs of detailing personnel and the fair market value of any supplies, equipment, or services provided by the Secretary. The Secretary shall, for the payment of expenses incurred in complying with such request, expend the amounts withheld.
<br>(f) Advisory Council
<br>(1) In general
<br>
<br>The Secretary shall establish an advisory council to be known as the Advisory Council for the Elimination of Tuberculosis (in this subsection referred to as the "Council").
<br>(2) Duties
<br>
<br>The Council shall provide advice and recommendations regarding the elimination of tuberculosis to the Secretary. In addition, the Council shall, with respect to eliminating such disease, provide to the Secretary and other appropriate Federal officials advice on—
<br>
<br>(A) coordinating the activities of the Department of Health and Human Services and other Federal agencies that relate to the disease, including activities under subsection (b);
<br>
<br>(B) responding rapidly and effectively to emerging issues in tuberculosis; and
<br>
<br>(C) efficiently utilizing the Federal resources involved.
<br>(3) Comprehensive plan
<br>(A) In general
<br>
<br>In carrying out paragraph (2), the Council shall make or update recommendations on the development, revision, and implementation of a comprehensive plan to eliminate tuberculosis in the United States.
<br>(B) Consultation
<br>
<br>In carrying out subparagraph (A), the Council may consult with appropriate public and private entities, which may, subject to the direction or discretion of the Secretary, include—
<br>
<br>(i) individuals who are scientists, physicians, laboratorians, and other health professionals, who are not officers or employees of the Federal Government and who represent the disciplines relevant to tuberculosis elimination;
<br>
<br>(ii) members of public-private partnerships or private entities established to address the elimination of tuberculosis;
<br>
<br>(iii) members of national and international nongovernmental organizations whose purpose is to eliminate tuberculosis;
<br>
<br>(iv) members from the general public who are knowledgeable with respect to tuberculosis elimination including individuals who have or have had tuberculosis; and
<br>
<br>(v) scientists, physicians, laboratorians, and other health professionals who reside in a foreign country with a substantial incidence or prevalence of tuberculosis, and who represent the specialties and disciplines relevant to the research under consideration.
<br>(C) Certain components of plan
<br>
<br>In carrying out subparagraph (A), the Council shall, subject to the direction or discretion of the Secretary—
<br>
<br>(i) consider recommendations for the involvement of the United States in continuing global and cross-border tuberculosis control activities in countries where a high incidence of tuberculosis directly affects the United States; and
<br>
<br>(ii) review the extent to which progress has been made toward eliminating tuberculosis.
<br>(4) Biennial report
<br>(A) In general
<br>
<br>The Council shall submit a biennial report to the Secretary, as determined necessary by the Secretary, on the activities carried under this section. Each such report shall include the opinion of the Council on the extent to which its recommendations regarding the elimination of tuberculosis have been implemented, including with respect to—
<br>
<br>(i) activities under subsection (b); and
<br>
<br>(ii) the national plan referred to in paragraph (3).
<br>(B) Public
<br>
<br>The Secretary shall make a report submitted under subparagraph (A) public.
<br>(5) Composition
<br>
<br>The Council shall be composed of—
<br>
<br>(A) ex officio representatives from the Centers for Disease Control and Prevention, the National Institutes of Health, the United States Agency for International Development, the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, the United States-Mexico Border Health Commission, and other Federal departments and agencies that carry out significant activities related to tuberculosis;
<br>
<br>(B) State and local tuberculosis control and public health officials;
<br>
<br>(C) individuals who are scientists, physicians, laboratorians, and other health professionals who represent disciplines relevant to tuberculosis elimination; and
<br>
<br>(D) members of national and international nongovernmental organizations established to address the elimination of tuberculosis.
<br>(6) Staff, information, and other assistance
<br>
<br>The Secretary shall provide to the Council such staff, information, and other assistance as may be necessary to carry out the duties of the Council.
<br>(g) Federal Tuberculosis Task Force
<br>(1) Duties
<br>
<br>The Federal Tuberculosis Task Force (in this subsection referred to as the "Task Force") shall provide to the Secretary and other appropriate Federal officials advice on research into new tools under subsection (b)(2), including advice regarding the efficient utilization of the Federal resources involved.
<br>(2) Comprehensive plan for new tools development
<br>
<br>In carrying out paragraph (1), the Task Force shall make recommendations on the development of a comprehensive plan for the creation of new tools for the elimination of tuberculosis, including drugs, diagnostics, and vaccines.
<br>(3) Consultation
<br>
<br>In developing the comprehensive plan under paragraph (1),2 the Task Force shall consult with external parties including representatives from groups such as—
<br>
<br>(A) scientists, physicians, laboratorians, and other health professionals who represent the specialties and disciplines relevant to the research under consideration;
<br>
<br>(B) members from public-private partnerships, private entities, or foundations (or both) engaged in activities relevant to research under consideration;
<br>
<br>(C) members of national and international nongovernmental organizations established to address tuberculosis elimination;
<br>
<br>(D) members from the general public who are knowledgeable with respect to tuberculosis including individuals who have or have had tuberculosis; and
<br>
<br>(E) scientists, physicians, laboratorians, and other health professionals who reside in a foreign country with a substantial incidence or prevalence of tuberculosis, and who represent the specialties and disciplines relevant to the research under consideration.
<br>(h) Authorization of appropriations
<br>(1) General program
<br>(A) In general
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated $200,000,000 for fiscal year 2009, $210,000,000 for fiscal year 2010, $220,500,000 for fiscal year 2011, $231,525,000 for fiscal year 2012, and $243,101,250 for fiscal year 2013.
<br>(B) Reservation for emergency grants
<br>
<br>Of the amounts appropriated under subparagraph (A) for a fiscal year, the Secretary may reserve not more than 25 percent for emergency grants under subsection (a) for any geographic area, State, political subdivision of a State, or other public entity in which there is, relative to other areas, a substantial number of cases of tuberculosis, multidrug resistant tuberculosis, or extensively drug resistant tuberculosis or a substantial rate of increase in such cases.
<br>(C) Priority
<br>
<br>In allocating amounts appropriated under subparagraph (A), the Secretary shall give priority to allocating such amounts for grants under subsection (a).
<br>(D) Allocation of funds
<br>(i) Requirement of formula
<br>
<br>Of the amounts appropriated under subparagraph (A), not reserved under subparagraph (B), and allocated by the Secretary for grants under subsection (a), the Secretary shall distribute a portion of such amounts to grantees under subsection (a) on the basis of a formula.
<br>(ii) Relevant factors
<br>
<br>The formula developed by the Secretary under clause (i) shall take into account the level of tuberculosis morbidity and case complexity in the respective geographic area and may consider other factors relevant to tuberculosis in such area.
<br>(iii) No change to formula required
<br>
<br>This subparagraph does not require the Secretary to modify the formula that was used by the Secretary to distribute funds to grantees under subsection (a) for fiscal year 2009.
<br>(2) Limitation
<br>
<br>The authorization of appropriations established in paragraph (1) for a fiscal year is effective only if the amount appropriated under such paragraph for such year equals or exceeds the amount appropriated to carry out this section for fiscal year 2009.
<br>
<br>(July 1, 1944, ch. 373, title III, §317E, as added Pub. L. 103–183, title III, §301(a), Dec. 14, 1993, 107 Stat. 2233; amended Pub. L. 105–392, title IV, §§401(b)(1), 405, Nov. 13, 1998, 112 Stat. 3587, 3588; Pub. L. 107–251, title VI, §601(a), Oct. 26, 2002, 116 Stat. 1664; Pub. L. 108–163, §2(m)(1), Dec. 6, 2003, 117 Stat. 2023; Pub. L. 110–392, title I, §§101, 111(a), (c), 131, Oct. 13, 2008, 122 Stat. 4196, 4197, 4199, 4200.)
<br>References in Text
<br>
<br>The reference to section 254b of this title the first place appearing, referred to in subsec. (c), was in the original a reference to section 329, meaning section 329 of act July 1, 1944, which was omitted in the general amendment of subpart I (§254b et seq.) of part D of this subchapter by Pub. L. 104–299, §2, Oct. 11, 1996, 110 Stat. 3626.
<br>
<br>Section 256a of this title, referred to in subsec. (c), was repealed by Pub. L. 104–299, §4(a)(3), Oct. 11, 1996, 110 Stat. 3645.
<br>Amendments
<br>
<br>2008—Pub. L. 110–392, §101(1), substituted "National strategy for combating and eliminating tuberculosis" for "Preventive health services regarding tuberculosis" in section catchline.
<br>
<br>Subsec. (b). Pub. L. 110–392, §101(2), amended subsec. (b) generally. Prior to amendment, subsec. (b) related to research, demonstration projects, education, and training for the purpose of prevention, control, and elimination of tuberculosis.
<br>
<br>Subsec. (d)(3). Pub. L. 110–392, §101(3), added par. (3).
<br>
<br>Subsec. (f)(2) to (6). Pub. L. 110–392, §111(a), added pars. (2) to (5), redesignated former par. (5) as (6), and struck out former pars. (2) to (4) which related to general duties, certain activities, and composition of the Council, respectively.
<br>
<br>Subsec. (g). Pub. L. 110–392, §111(c)(2), added subsec. (g). Former subsec. (g) redesignated (h).
<br>
<br>Subsec. (h). Pub. L. 110–392, §131, added subsec. (h) and struck out former subsec. (h) which authorized appropriations for grants, research, demonstration projects, education, and training for fiscal years 1994 to 2002.
<br>
<br>Pub. L. 110–392, §111(c)(1), redesignated subsec. (g) as (h).
<br>
<br>2003—Subsec. (c). Pub. L. 108–163 substituted "254b" for "254c, 254b(h)" before ", or".
<br>
<br>2002—Subsec. (c). Pub. L. 107–251 substituted "254b(h)" for "256".
<br>
<br>1998—Subsec. (g)(1)(A). Pub. L. 105–392, §405(1)(A), substituted "2002" for "1998".
<br>
<br>Subsec. (g)(1)(B). Pub. L. 105–392, §405(1)(B), substituted "25 percent" for "$50,000,000".
<br>
<br>Subsec. (g)(2). Pub. L. 105–392, §405(2), substituted "2002" for "1998".
<br>
<br>Pub. L. 105–392, §401(b)(1), substituted "carrying out subsection (b)" for "making grants under subsection (b)".
<br>Effective Date of 2003 Amendment
<br>
<br>Amendment by Pub. L. 108–163 deemed to have taken effect immediately after the enactment of Pub. L. 107–251, see section 3 of Pub. L. 108–163, set out as a note under section 233 of this title.
<br>Effective Date of 1998 Amendment
<br>
<br>Amendment by section 401(b)(1) of Pub. L. 105–392 deemed to have taken effect immediately after enactment of Pub. L. 103–183, see section 401(e) of Pub. L. 105–392, set out as a note under section 242m of this title.
<br>Construction of 2008 Amendment
<br>
<br>Pub. L. 110–392, title I, §111(b), Oct. 13, 2008, 122 Stat. 4199, provided that: "With respect to the advisory council under section 317E(f) of the Public Health Service Act [42 U.S.C. 247b–6(f)], the amendments made by subsection (a) [amending this section] may not be construed as terminating the membership on such council of any individual serving as such a member as of the day before the date of the enactment of this Act [Oct. 13, 2008]."
<br>Termination of Advisory Councils
<br>
<br>Advisory councils established after Jan. 5, 1973, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a council established by the President or an officer of the Federal Government, such council is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a council established by Congress, its duration is otherwise provided by law. See sections 3(2) and 14 of Pub. L. 92–463, Oct. 6, 1972, 86 Stat. 770, 776, set out in the Appendix to Title 5, Government Organization and Employees.
<br>
<br>Pub. L. 93–641, §6, Jan. 4, 1975, 88 Stat. 2275, set out as a note under section 217a of this title, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after Jan. 4, 1975.
<br>
<br>1 See References in Text notes below.
<br>
<br>2 So in original. Probably should be "paragraph (2),".
<br>§247b–7. Loan repayment program
<br>(a) In general
<br>(1) Authority
<br>
<br>Subject to paragraph (2), the Secretary may carry out a program of entering into contracts with appropriately qualified health professionals under which such health professionals agree to conduct prevention activities or preparedness and response activities, including rapid response to public health emergencies and significant public health threats, as employees of the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry, in consideration of the Federal Government agreeing to repay, for each year of such service, not more than $50,000 of the principal and interest of the educational loans of such health professionals.
<br>(2) Limitation
<br>
<br>The Secretary may not enter into an agreement with a health professional pursuant to paragraph (1) unless such professional—
<br>
<br>(A) has a substantial amount of educational loans relative to income; and
<br>
<br>(B) agrees to serve as an employee of the Centers for Disease Control and Prevention or the Agency for Toxic Substances and Disease Registry for purposes of paragraph (1) for a period of not less than 2 years.
<br>(b) Applicability of certain provisions
<br>
<br>With respect to the National Health Service Corps Loan Repayment Program established in subpart III of part D of this subchapter, the provisions of such subpart shall, except as inconsistent with subsection (a), apply to the program established in this section in the same manner and to the same extent as such provisions apply to the National Health Service Corps Loan Repayment Program.
<br>(c) Authorization of appropriations
<br>(1) In general
<br>
<br>For the purpose of carrying out this section, except as described in paragraph (2), there are authorized to be appropriated $500,000 for fiscal year 1994, and such sums as may be necessary for each of the fiscal years 1995 through 2002.
<br>(2) Epidemic Intelligence Service program
<br>
<br>For purposes of carrying out this section with respect to qualified health professionals serving in the Epidemic Intelligence Service, as authorized under section 247b–8 of this title, there is authorized to be appropriated $1,000,000 for each of fiscal years 2019 through 2023.
<br>(d) Availability of appropriations
<br>
<br>Amounts appropriated for a fiscal year for contracts under subsection (a) shall remain available until the expiration of the second fiscal year beginning after the fiscal year for which the amounts were appropriated.
<br>
<br>(July 1, 1944, ch. 373, title III, §317F, as added Pub. L. 103–183, title VII, §703, Dec. 14, 1993, 107 Stat. 2240; amended Pub. L. 105–392, title IV, §406, Nov. 13, 1998, 112 Stat. 3588; Pub. L. 116–22, title III, §301(c), June 24, 2019, 133 Stat. 932.)
<br>Amendments
<br>
<br>2019—Subsec. (a)(1). Pub. L. 116–22, §301(c)(1)(A), inserted "or preparedness and response activities, including rapid response to public health emergencies and significant public health threats" after "conduct prevention activities" and substituted "$50,000" for "$35,000".
<br>
<br>Subsec. (a)(2)(B). Pub. L. 116–22, §301(c)(1)(B), substituted "2 years" for "3 years".
<br>
<br>Subsec. (c). Pub. L. 116–22, §301(c)(2), designated existing provisions as par. (1), inserted heading, substituted "For the purpose of carrying out this section, except as described in paragraph (2)" for "For the purpose of carrying out this section", and added par. (2).
<br>
<br>1998—Subsec. (a)(1). Pub. L. 105–392, §406(1), substituted "$35,000" for "$20,000".
<br>
<br>Subsec. (c). Pub. L. 105–392, §406(2), substituted "2002" for "1998".
<br>
<br>Subsec. (d). Pub. L. 105–392, §406(3), added subsec. (d).
<br>§247b–8. Fellowship and training programs
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish fellowship and training programs to be conducted by such Centers to train individuals to develop skills in epidemiology, surveillance, laboratory analysis, and other disease detection and prevention methods. Such programs shall be designed to enable health professionals and health personnel trained under such programs to work, after receiving such training, in local, State, national, and international efforts toward the prevention and control of diseases, injuries, and disabilities. Such fellowships and training may be administered through the use of either appointment or nonappointment procedures.
<br>
<br>(July 1, 1944, ch. 373, title III, §317G, as added Pub. L. 105–115, title IV, §408(b)(1), Nov. 21, 1997, 111 Stat. 2371.)
<br>Effective Date
<br>
<br>Pub. L. 105–115, title IV, §408(b)(2), Nov. 21, 1997, 111 Stat. 2371, provided that: "The amendment made by this subsection [enacting this section] is deemed to have taken effect July 1, 1995."
<br>§247b–9. Diabetes in children and youth
<br>(a) Surveillance on juvenile diabetes
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall develop a sentinel system to collect data on juvenile diabetes, including with respect to incidence and prevalence, and shall establish a national database for such data.
<br>(b) Type 2 diabetes in youth
<br>
<br>The Secretary shall implement a national public health effort to address type 2 diabetes in youth, including—
<br>
<br>(1) enhancing surveillance systems and expanding research to better assess the prevalence and incidence of type 2 diabetes in youth and determine the extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes among children; and
<br>
<br>(2) developing and improving laboratory methods to assist in diagnosis, treatment, and prevention of diabetes including, but not limited to, developing noninvasive ways to monitor blood glucose to prevent hypoglycemia and improving existing glucometers that measure blood glucose.
<br>(c) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.
<br>
<br>(July 1, 1944, ch. 373, title III, §317H, as added Pub. L. 106–310, div. A, title IV, §401, Oct. 17, 2000, 114 Stat. 1112.)
<br>§247b–9a. Better diabetes care
<br>(a) Short title
<br>
<br>This section may be cited as the "Catalyst to Better Diabetes Care Act of 2009".
<br>(b) National diabetes report card
<br>(1) In general
<br>
<br>The Secretary, in collaboration with the Director of the Centers for Disease Control and Prevention (referred to in this section as the "Director"), shall prepare on a biennial basis a national diabetes report card (referred to in this section as a "Report Card") and, to the extent possible, for each State.1
<br>(2) Contents
<br>(A) In general
<br>
<br>Each Report Card shall include aggregate health outcomes related to individuals diagnosed with diabetes and prediabetes including—
<br>
<br>(i) preventative care practices and quality of care;
<br>
<br>(ii) risk factors; and
<br>
<br>(iii) outcomes.
<br>(B) Updated reports
<br>
<br>Each Report Card that is prepared after the initial Report Card shall include trend analysis for the Nation and, to the extent possible, for each State, for the purpose of—
<br>
<br>(i) tracking progress in meeting established national goals and objectives for improving diabetes care, costs, and prevalence (including Healthy People 2010); and
<br>
<br>(ii) informing policy and program development.
<br>(3) Availability
<br>
<br>The Secretary, in collaboration with the Director, shall make each Report Card publicly available, including by posting the Report Card on the Internet.
<br>(c) Improvement of vital statistics collection
<br>(1) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in collaboration with appropriate agencies and States, shall—
<br>
<br>(A) promote the education and training of physicians on the importance of birth and death certificate data and how to properly complete these documents, including the collection of such data for diabetes and other chronic diseases;
<br>
<br>(B) encourage State adoption of the latest standard revisions of birth and death certificates; and
<br>
<br>(C) work with States to re-engineer their vital statistics systems in order to provide cost-effective, timely, and accurate vital systems data.
<br>(2) Death certificate additional language
<br>
<br>In carrying out this subsection, the Secretary may promote improvements to the collection of diabetes mortality data, including the addition of a question for the individual certifying the cause of death regarding whether the deceased had diabetes.
<br>(d) Study on appropriate level of diabetes medical education
<br>(1) In general
<br>
<br>The Secretary shall, in collaboration with the Institute of Medicine and appropriate associations and councils, conduct a study of the impact of diabetes on the practice of medicine in the United States and the appropriateness of the level of diabetes medical education that should be required prior to licensure, board certification, and board recertification.
<br>(2) Report
<br>
<br>Not later than 2 years after March 23, 2010, the Secretary shall submit a report on the study under paragraph (1) to the Committees on Ways and Means and Energy and Commerce of the House of Representatives and the Committees on Finance and Health, Education, Labor, and Pensions of the Senate.
<br>(e) Authorization of appropriations
<br>
<br>There are authorized to be appropriated to carry out this section such sums as may be necessary.
<br>
<br>(Pub. L. 111–148, title X, §10407, Mar. 23, 2010, 124 Stat. 976.)
<br>Codification
<br>
<br>Section was enacted as part of the Patient Protection and Affordable Care Act, and not as part of the Public Health Service Act which comprises this chapter.
<br>
<br>1 So in original.
<br>§247b–10. Compilation of data on asthma
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall—
<br>
<br>(1) conduct local asthma surveillance activities to collect data on the prevalence and severity of asthma and the quality of asthma management;
<br>
<br>(2) compile and annually publish data on the prevalence of children suffering from asthma in each State; and
<br>
<br>(3) to the extent practicable, compile and publish data on the childhood mortality rate associated with asthma nationally.
<br>(b) Surveillance activities
<br>
<br>The Director of the Centers for Disease Control and Prevention, acting through the representative of the Director on the National Asthma Education Prevention Program Coordinating Committee, shall, in carrying out subsection (a), provide an update on surveillance activities at each Committee meeting.
<br>(c) Collaborative efforts
<br>
<br>The activities described in subsection (a)(1) may be conducted in collaboration with eligible entities awarded a grant under section 280g of this title.
<br>(d) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.
<br>
<br>(July 1, 1944, ch. 373, title III, §317I, as added Pub. L. 106–310, div. A, title V, §531, Oct. 17, 2000, 114 Stat. 1117.)
<br>§247b–11. Effects of folic acid in prevention of birth defects
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall expand and intensify programs (directly or through grants or contracts) for the following purposes:
<br>
<br>(1) To provide education and training for health professionals and the general public for purposes of explaining the effects of folic acid in preventing birth defects and for purposes of encouraging each woman of reproductive capacity (whether or not planning a pregnancy) to consume on a daily basis a dietary supplement that provides an appropriate level of folic acid.
<br>
<br>(2) To conduct research with respect to such education and training, including identifying effective strategies for increasing the rate of consumption of folic acid by women of reproductive capacity.
<br>
<br>(3) To conduct research to increase the understanding of the effects of folic acid in preventing birth defects, including understanding with respect to cleft lip, cleft palate, and heart defects.
<br>
<br>(4) To provide for appropriate epidemiological activities regarding folic acid and birth defects, including epidemiological activities regarding neural tube defects.
<br>(b) Consultations with States and private entities
<br>
<br>In carrying out subsection (a), the Secretary shall consult with the States and with other appropriate public or private entities, including national nonprofit private organizations, health professionals, and providers of health insurance and health plans.
<br>(c) Technical assistance
<br>
<br>The Secretary may (directly or through grants or contracts) provide technical assistance to public and nonprofit private entities in carrying out the activities described in subsection (a).
<br>(d) Evaluations
<br>
<br>The Secretary shall (directly or through grants or contracts) provide for the evaluation of activities under subsection (a) in order to determine the extent to which such activities have been effective in carrying out the purposes of the program under such subsection, including the effects on various demographic populations. Methods of evaluation under the preceding sentence may include surveys of knowledge and attitudes on the consumption of folic acid and on blood folate levels. Such methods may include complete and timely monitoring of infants who are born with neural tube defects.
<br>(e) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.
<br>
<br>(July 1, 1944, ch. 373, title III, §317J, as added Pub. L. 106–310, div. A, title VI, §601, Oct. 17, 2000, 114 Stat. 1118.)
<br>§247b–12. Safe motherhood
<br>(a) Surveillance
<br>(1) Purpose
<br>
<br>The purposes of this subsection are to establish or continue a Federal initiative to support State and tribal maternal mortality review committees, to improve data collection and reporting around maternal mortality, and to develop or support surveillance systems at the local, State, and national level to better understand the burden of maternal complications and mortality and to decrease the disparities among populations at risk of death and severe complications from pregnancy.
<br>(2) Activities
<br>
<br>For the purpose described in paragraph (1), the Secretary, acting through the Director of the Centers for Disease Control and Prevention, may carry out the following activities:
<br>
<br>(A) The Secretary may continue and improve activities related to a national maternal mortality data collection and surveillance program to identify and support the review of pregnancy-associated deaths and pregnancy-related deaths that occur during, or within 1 year following, pregnancy.
<br>
<br>(B) The Secretary may expand the Pregnancy Risk Assessment Monitoring System to provide surveillance and collect data in each State.
<br>
<br>(C) The Secretary may expand the Maternal and Child Health Epidemiology Program to provide technical support, financial assistance, or the time-limited assignment of senior epidemiologists to maternal and child health programs in each State.
<br>
<br>(D) The Secretary may, in cooperation with States, Indian tribes, and tribal organizations, develop a program to support States, Indian tribes, and tribal organizations in establishing or operating maternal mortality review committees, in accordance with subsection (d).
<br>(b) Prevention research
<br>(1) Purpose
<br>
<br>The purpose of this subsection is to provide the Secretary with the authority to further expand research concerning risk factors, prevention strategies, and the roles of the family, health care providers and the community in safe motherhood.
<br>(2) Research
<br>
<br>The Secretary may carry out activities to expand research relating to—
<br>
<br>(A) prepregnancy counseling, especially for at risk populations such as women with diabetes and women with substance use disorder;
<br>
<br>(B) the identification of critical components of prenatal delivery and postpartum care;
<br>
<br>(C) the identification of outreach and support services, such as folic acid education, that are available for pregnant women;
<br>
<br>(D) the identification of women who are at high risk for complications;
<br>
<br>(E) preventing preterm delivery;
<br>
<br>(F) preventing urinary tract infections;
<br>
<br>(G) preventing unnecessary caesarean sections;
<br>
<br>(H) the identification of the determinants of disparities in maternal care, health risks, and health outcomes, including an examination of the higher rates of maternal mortality among African American women and other groups of women with disproportionately high rates of maternal mortality;
<br>
<br>(I) activities to reduce disparities in maternity services and outcomes;
<br>
<br>(J) an examination of the relationship between interpersonal violence and maternal complications and mortality;
<br>
<br>(K) preventing and reducing adverse health consequences that may result from smoking and substance abuse and misuse before, during and after pregnancy;
<br>
<br>(L) preventing infections that cause maternal and infant complications; and
<br>
<br>(M) other areas determined appropriate by the Secretary.
<br>(c) Prevention programs
<br>
<br>The Secretary may carry out activities to promote safe motherhood, including—
<br>
<br>(1) public education campaigns on healthy pregnancies;
<br>
<br>(2) education programs for physicians, nurses and other health care providers;
<br>
<br>(3) activities to promote community support services for pregnant women; and
<br>
<br>(4) activities to promote physical, mental, and behavioral health during, and up to 1 year following, pregnancy, with an emphasis on prevention of, and treatment for, mental health disorders and substance use disorder.
<br>(d) Maternal mortality review committees
<br>(1) In general
<br>
<br>In order to participate in the program under subsection (a)(2)(D), the applicable maternal mortality review committee of the State, Indian tribe, or tribal organization shall—
<br>
<br>(A) include multidisciplinary and diverse membership that represents a variety of clinical specialties, State, tribal, or local public health officials, epidemiologists, statisticians, community organizations, geographic regions within the area covered by such committee, and individuals or organizations that represent the populations in the area covered by such committee that are most affected by pregnancy-related deaths or pregnancy-associated deaths and lack of access to maternal health care services; and
<br>
<br>(B) demonstrate to the Centers for Disease Control and Prevention that such maternal mortality review committee's methods and processes for data collection and review, as required under paragraph (3), use best practices to reliably determine and include all pregnancy-associated deaths and pregnancy-related deaths, regardless of the outcome of the pregnancy.
<br>(2) Process for confidential reporting
<br>
<br>States, Indian tribes, and tribal organizations that participate in the program described in this subsection shall, through the State maternal mortality review committee, develop a process that—
<br>
<br>(A) provides for confidential case reporting of pregnancy-associated and pregnancy-related deaths to the appropriate State or tribal health agency, including such reporting by—
<br>
<br>(i) health care professionals;
<br>
<br>(ii) health care facilities;
<br>
<br>(iii) any individual responsible for completing death records, including medical examiners and medical coroners; and
<br>
<br>(iv) other appropriate individuals or entities; and
<br>
<br>(B) provides for voluntary and confidential case reporting of pregnancy-associated deaths and pregnancy-related deaths to the appropriate State or tribal health agency by family members of the deceased, and other appropriate individuals, for purposes of review by the applicable maternal mortality review committee; and
<br>
<br>(C) shall include—
<br>
<br>(i) making publicly available contact information of the committee for use in such reporting; and
<br>
<br>(ii) conducting outreach to local professional organizations, community organizations, and social services agencies regarding the availability of the review committee.
<br>(3) Data collection and review
<br>
<br>States, Indian tribes, and tribal organizations that participate in the program described in this subsection shall—
<br>
<br>(A) annually identify pregnancy-associated deaths and pregnancy-related deaths—
<br>
<br>(i) through the appropriate vital statistics unit by—
<br>
<br>(I) matching each death record related to a pregnancy-associated death or pregnancy-related death in the State or tribal area in the applicable year to a birth certificate of an infant or fetal death record, as applicable;
<br>
<br>(II) to the extent practicable, identifying an underlying or contributing cause of each pregnancy-associated death and each pregnancy-related death in the State or tribal area in the applicable year; and
<br>
<br>(III) collecting data from medical examiner and coroner reports, as appropriate;
<br>
<br>(ii) using other appropriate methods or information to identify pregnancy-associated deaths and pregnancy-related deaths, including deaths from pregnancy outcomes not identified through clause (i)(I);
<br>
<br>(B) through the maternal mortality review committee, review data and information to identify adverse outcomes that may contribute to pregnancy-associated death and pregnancy-related death, and to identify trends, patterns, and disparities in such adverse outcomes to allow the State, Indian tribe, or tribal organization to make recommendations to individuals and entities described in paragraph (2)(A), as appropriate, to improve maternal care and reduce pregnancy-associated death and pregnancy-related death;
<br>
<br>(C) identify training available to the individuals and entities described in paragraph (2)(A) for accurate identification and reporting of pregnancy-associated and pregnancy-related deaths;
<br>
<br>(D) ensure that, to the extent practicable, the data collected and reported under this paragraph is in a format that allows for analysis by the Centers for Disease Control and Prevention; and
<br>
<br>(E) publicly identify the methods used to identify pregnancy-associated deaths and pregnancy-related deaths in accordance with this section.
<br>(4) Confidentiality
<br>
<br>States, Indian tribes, and tribal organizations participating in the program described in this subsection shall establish confidentiality protections to ensure, at a minimum, that—
<br>
<br>(A) there is no disclosure by the maternal mortality review committee, including any individual members of the committee, to any person, including any government official, of any identifying information about any specific maternal mortality case; and
<br>
<br>(B) no information from committee proceedings, including deliberation or records, is made public unless specifically authorized under State and Federal law.
<br>(5) Reports to CDC
<br>
<br>For fiscal year 2019, and each subsequent fiscal year, each maternal mortality review committee participating in the program described in this subsection shall submit to the Director of the Centers for Disease Control and Prevention a report that includes—
<br>
<br>(A) data, findings, and any recommendations of such committee; and
<br>
<br>(B) as applicable, information on the implementation during such year of any recommendations submitted by the committee in a previous year.
<br>(6) State partnerships
<br>
<br>States may partner with one or more neighboring States to carry out the activities under this subparagraph. With respect to the States in such a partnership, any requirement under this subparagraph relating to the reporting of information related to such activities shall be deemed to be fulfilled by each such State if a single such report is submitted for the partnership.
<br>(7) Appropriate mechanisms for Indian tribes and tribal organizations
<br>
<br>The Secretary, in consultation with Indian tribes, shall identify and establish appropriate mechanisms for Indian tribes and tribal organizations to demonstrate, report data, and conduct the activities as required for participation in the program described in this subsection. Such mechanisms may include technical assistance with respect to grant application and submission procedures, and award management activities.
<br>(8) Research availability
<br>
<br>The Secretary shall develop a process to ensure that data collected under paragraph (5) is made available, as appropriate and practicable, for research purposes, in a manner that protects individually identifiable or potentially identifiable information and that is consistent with State and Federal privacy law.
<br>(e) Definitions
<br>
<br>In this section—
<br>
<br>(1) the terms "Indian tribe" and "tribal organization" have the meanings given such terms in section 5304 of title 25;
<br>
<br>(2) the term "pregnancy-associated death" means a death of a woman, by any cause, that occurs during, or within 1 year following, her pregnancy, regardless of the outcome, duration, or site of the pregnancy; and
<br>
<br>(3) the term "pregnancy-related death" means a death of a woman that occurs during, or within 1 year following, her pregnancy, regardless of the outcome, duration, or site of the pregnancy—
<br>
<br>(A) from any cause related to, or aggravated by, the pregnancy or its management; and
<br>
<br>(B) not from accidental or incidental causes.
<br>(f) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated $58,000,000 for each of fiscal years 2019 through 2023.
<br>
<br>(July 1, 1944, ch. 373, title III, §317K, as added Pub. L. 106–310, div. A, title IX, §901, Oct. 17, 2000, 114 Stat. 1125; amended Pub. L. 115–344, §2, Dec. 21, 2018, 132 Stat. 5047.)
<br>Amendments
<br>
<br>2018—Subsec. (a)(1). Pub. L. 115–344, §2(1)(A), substituted "purposes of this subsection are to establish or continue a Federal initiative to support State and tribal maternal mortality review committees, to improve data collection and reporting around maternal mortality, and to develop or support" for "purpose of this subsection is to develop" and "populations at risk of death and severe" for "population at risk of death and".
<br>
<br>Subsec. (a)(2)(A). Pub. L. 115–344, §2(1)(B)(i), amended subpar. (A) generally. Prior to amendment, subpar. (A) read as follows: "The Secretary may establish and implement a national surveillance program to identify and promote the investigation of deaths and severe complications that occur during pregnancy."
<br>
<br>Subsec. (a)(2)(D). Pub. L. 115–344, §2(1)(B)(ii), added subpar. (D).
<br>
<br>Subsec. (b)(2)(A). Pub. L. 115–344, §2(2)(A), substituted "prepregnancy" for "encouraging preconception" and "women with diabetes and women with substance use disorder" for "diabetics".
<br>
<br>Subsec. (b)(2)(H). Pub. L. 115–344, §2(2)(B), inserted "the identification of the determinants of disparities in maternal care, health risks, and health outcomes, including" before "an examination" and "and other groups of women with disproportionately high rates of maternal mortality" before semicolon at end.
<br>
<br>Subsec. (b)(2)(I). Pub. L. 115–344, §2(2)(E), added subpar. (I). Former subpar. (I) redesignated (J).
<br>
<br>Pub. L. 115–344, §2(2)(C), substituted "interpersonal" for "domestic".
<br>
<br>Subsec. (b)(2)(J). Pub. L. 115–344, §2(2)(D), redesignated subpar. (I) as (J). Former subpar. (J) redesignated (K).
<br>
<br>Subsec. (b)(2)(K). Pub. L. 115–344, §2(2)(D), (F), redesignated subpar. (J) as (K) and substituted "and substance abuse and misuse" for ", alcohol and illegal drug use". Former subpar. (K) redesignated (L).
<br>
<br>Subsec. (b)(2)(L), (M). Pub. L. 115–344, §2(2)(D), redesignated subpars. (K) and (L) as (L) and (M), respectively.
<br>
<br>Subsec. (c). Pub. L. 115–344, §2(3)(A), (B), struck out par. (1) designation and heading "In general" before "The Secretary" and redesignated subpars. (A) to (C) of former par. (1) as pars. (1) to (3), respectively. Amendment was executed to reflect the probable intent of Congress notwithstanding minor error in quoted par. (1) heading in original text directed to be struck out.
<br>
<br>Subsec. (c)(1). Pub. L. 115–344, §2(3)(C), struck out "and the building of partnerships with outside organizations concerned about safe motherhood" after "pregnancies".
<br>
<br>Subsec. (c)(4). Pub. L. 115–344, §2(3)(D)–(F), added par. (4).
<br>
<br>Subsecs. (d), (e). Pub. L. 115–344, §2(5), added subsecs. (d) and (e). Former subsec. (d) redesignated (f).
<br>
<br>Subsec. (f). Pub. L. 115–344, §2(4), (6), redesignated subsec. (d) as (f) and substituted "$58,000,000 for each of fiscal years 2019 through 2023" for "such sums as may be necessary for each of the fiscal years 2001 through 2005".
<br>§247b–13. Prenatal and postnatal health
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out programs—
<br>
<br>(1) to collect, analyze, and make available data on prenatal smoking and alcohol and other substance abuse and misuse, including—
<br>
<br>(A) data on—
<br>
<br>(i) the incidence, prevalence, and implications of such activities; and
<br>
<br>(ii) the incidence and prevalence of implications and outcomes, including neonatal abstinence syndrome and other maternal and child health outcomes associated with such activities; and
<br>
<br>(B) additional information or data, as appropriate, on family health history, medication exposures during pregnancy, demographic information, such as race, ethnicity, geographic location, and family history, and other relevant information, to inform such analysis;
<br>
<br>(2) to conduct applied epidemiological research on the prevention and long-term outcomes associated with prenatal and postnatal smoking, alcohol and other substance abuse and misuse;
<br>
<br>(3) to support, conduct, and evaluate the effectiveness of educational, treatment, and cessation programs;
<br>
<br>(4) to provide information and education to the public on the prevention and implications of prenatal and postnatal smoking, alcohol and other substance abuse and misuse; and
<br>
<br>(5) to issue public reports on the analysis of data described in paragraph (1), including analysis of—
<br>
<br>(A) long-term outcomes of children affected by neonatal abstinence syndrome;
<br>
<br>(B) health outcomes associated with prenatal smoking, alcohol, and substance abuse and misuse; and
<br>
<br>(C) relevant studies, evaluations, or information the Secretary determines to be appropriate.
<br>(b) Grants
<br>
<br>In carrying out subsection (a), the Secretary may award grants to and enter into contracts with States, local governments, tribal entities, scientific and academic institutions, federally qualified health centers, and other public and nonprofit entities, and may provide technical and consultative assistance to such entities.
<br>(c) Coordinating activities
<br>
<br>To carry out this section, the Secretary may—
<br>
<br>(1) provide technical and consultative assistance to entities receiving grants under subsection (b);
<br>
<br>(2) ensure a pathway for data sharing between States, tribal entities, and the Centers for Disease Control and Prevention;
<br>
<br>(3) ensure data collection under this section is consistent with applicable State, Federal, and Tribal privacy laws; and
<br>
<br>(4) coordinate with the National Coordinator for Health Information Technology, as appropriate, to assist States and Tribes in implementing systems that use standards recognized by such National Coordinator, as such recognized standards are available, in order to facilitate interoperability between such systems and health information technology systems, including certified health information technology.
<br>(d) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2019 through 2023.
<br>
<br>(July 1, 1944, ch. 373, title III, §317L, as added Pub. L. 106–310, div. A, title IX, §911, Oct. 17, 2000, 114 Stat. 1127; amended Pub. L. 115–271, title VII, §7064, Oct. 24, 2018, 132 Stat. 4021.)
<br>Amendments
<br>
<br>2018—Subsec. (a)(1). Pub. L. 115–271, §7064(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: "to collect, analyze, and make available data on prenatal smoking, alcohol and illegal drug use, including data on the implications of such activities and on the incidence and prevalence of such activities and their implications;".
<br>
<br>Subsec. (a)(2). Pub. L. 115–271, §7064(1)(B), substituted "prevention and long-term outcomes associated with" for "prevention of" and "other substance abuse and misuse" for "illegal drug use".
<br>
<br>Subsec. (a)(3). Pub. L. 115–271, §7064(1)(C), substituted ", treatment, and cessation programs;" for "and cessation programs; and".
<br>
<br>Subsec. (a)(4). Pub. L. 115–271, §7064(1)(D), substituted "other substance abuse and misuse; and" for "illegal drug use.".
<br>
<br>Subsec. (a)(5). Pub. L. 115–271, §7064(1)(E), added par. (5).
<br>
<br>Subsec. (b). Pub. L. 115–271, §7064(2), inserted "tribal entities," after "local governments,".
<br>
<br>Subsec. (c). Pub. L. 115–271, §7064(4), added subsec. (c). Former subsec. (c) redesignated (d).
<br>
<br>Subsec. (d). Pub. L. 115–271, §7064(3), (5), redesignated subsec. (c) as (d) and substituted "2019 through 2023" for "2001 through 2005".
<br>Improving Data and the Public Health Response
<br>
<br>Pub. L. 114–91, §4, Nov. 25, 2015, 129 Stat. 725, provided that: "The Secretary [of Health and Human Services] may continue activities, as appropriate, related to—
<br>
<br>"(1) providing technical assistance to support States and Federally recognized Indian Tribes in collecting information on neonatal abstinence syndrome through the utilization of existing surveillance systems and collaborating with States and Federally recognized Indian Tribes to improve the quality, consistency, and collection of such data; and
<br>
<br>"(2) providing technical assistance to support States in implementing effective public health measures, such as disseminating information to educate the public, health care providers, and other stakeholders on prenatal opioid use and neonatal abstinence syndrome."
<br>§247b–13a. Screening and treatment for maternal depression
<br>(a) Grants
<br>
<br>The Secretary shall make grants to States to establish, improve, or maintain programs for screening, assessment, and treatment services, including culturally and linguistically appropriate services, as appropriate, for women who are pregnant, or who have given birth within the preceding 12 months, for maternal depression.
<br>(b) Application
<br>
<br>To seek a grant under this section, a State shall submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require. At a minimum, any such application shall include explanations of—
<br>
<br>(1) how a program, or programs, will increase the percentage of women screened and treated, as appropriate, for maternal depression in 1 or more communities; and
<br>
<br>(2) how a program, or programs, if expanded, would increase access to screening and treatment services for maternal depression.
<br>(c) Priority
<br>
<br>In awarding grants under this section, the Secretary may give priority to States proposing to improve or enhance access to screening services for maternal depression in primary care settings.
<br>(d) Use of funds
<br>
<br>The activities eligible for funding through a grant under subsection (a)—
<br>
<br>(1) shall include—
<br>
<br>(A) providing appropriate training to health care providers; and
<br>
<br>(B) providing information to health care providers, including information on maternal depression screening, treatment, and followup support services, and linkages to community-based resources; and
<br>
<br>(2) may include—
<br>
<br>(A) enabling health care providers (including obstetrician-gynecologists, pediatricians, psychiatrists, mental health care providers, and adult primary care clinicians) to provide or receive real-time psychiatric consultation (in-person or remotely) to aid in the treatment of pregnant and parenting women;
<br>
<br>(B) establishing linkages with and among community-based resources, including mental health resources, primary care resources, and support groups; and
<br>
<br>(C) utilizing telehealth services for rural areas and medically underserved areas (as defined in section 254c–14(a) of this title).
<br>(e) Authorization of appropriations
<br>
<br>To carry out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2018 through 2022.
<br>
<br>(July 1, 1944, ch. 373, title III, §317L–1, as added Pub. L. 114–255, div. B, title X, §10005, Dec. 13, 2016, 130 Stat. 1266.)
<br>§247b–14. Oral health promotion and disease prevention
<br>(a) Grants to increase resources for community water fluoridation
<br>(1) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States and Indian tribes for the purpose of increasing the resources available for community water fluoridation.
<br>(2) Use of funds
<br>
<br>A State shall use amounts provided under a grant under paragraph (1)—
<br>
<br>(A) to purchase fluoridation equipment;
<br>
<br>(B) to train fluoridation engineers;
<br>
<br>(C) to develop educational materials on the benefits of fluoridation; or
<br>
<br>(D) to support the infrastructure necessary to monitor and maintain the quality of water fluoridation.
<br>(b) Community water fluoridation
<br>(1) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in collaboration with the Director of the Indian Health Service, shall establish a demonstration project that is designed to assist rural water systems in successfully implementing the water fluoridation guidelines of the Centers for Disease Control and Prevention that are entitled "Engineering and Administrative Recommendations for Water Fluoridation, 1995" (referred to in this subsection as the "EARWF").
<br>(2) Requirements
<br>(A) Collaboration
<br>
<br>In collaborating under paragraph (1), the Directors referred to in such paragraph shall ensure that technical assistance and training are provided to tribal programs located in each of the 12 areas of the Indian Health Service. The Director of the Indian Health Service shall provide coordination and administrative support to tribes under this section.
<br>(B) General use of funds
<br>
<br>Amounts made available under paragraph (1) shall be used to assist small water systems in improving the effectiveness of water fluoridation and to meet the recommendations of the EARWF.
<br>(C) Fluoridation specialists
<br>(i) In general
<br>
<br>In carrying out this subsection, the Secretary shall provide for the establishment of fluoridation specialist engineering positions in each of the Dental Clinical and Preventive Support Centers through which technical assistance and training will be provided to tribal water operators, tribal utility operators and other Indian Health Service personnel working directly with fluoridation projects.
<br>(ii) Liaison
<br>
<br>A fluoridation specialist shall serve as the principal technical liaison between the Indian Health Service and the Centers for Disease Control and Prevention with respect to engineering and fluoridation issues.
<br>(iii) CDC
<br>
<br>The Director of the Centers for Disease Control and Prevention shall appoint individuals to serve as the fluoridation specialists.
<br>(D) Implementation
<br>
<br>The project established under this subsection shall be planned, implemented and evaluated over the 5-year period beginning on the date on which funds are appropriated under this section and shall be designed to serve as a model for improving the effectiveness of water fluoridation systems of small rural communities.
<br>(3) Evaluation
<br>
<br>In conducting the ongoing evaluation as provided for in paragraph (2)(D), the Secretary shall ensure that such evaluation includes—
<br>
<br>(A) the measurement of changes in water fluoridation compliance levels resulting from assistance provided under this section;
<br>
<br>(B) the identification of the administrative, technical and operational challenges that are unique to the fluoridation of small water systems;
<br>
<br>(C) the development of a practical model that may be easily utilized by other tribal, State, county or local governments in improving the quality of water fluoridation with emphasis on small water systems; and
<br>
<br>(D) the measurement of any increased percentage of Native Americans or Alaskan Natives who receive the benefits of optimally fluoridated water.
<br>(c) School-based dental sealant program
<br>(1) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in collaboration with the Administrator of the Health Resources and Services Administration, shall award a grant to each of the 50 States and territories and to Indians, Indian tribes, tribal organizations and urban Indian organizations (as such terms are defined in section 1603 of title 25) to provide for the development of school-based dental sealant programs to improve the access of children to sealants.
<br>(2) Use of funds
<br>
<br>A State shall use amounts received under a grant under paragraph (1) to provide funds to eligible school-based entities or to public elementary or secondary schools to enable such entities or schools to provide children with access to dental care and dental sealant services. Such services shall be provided by licensed dental health professionals in accordance with State practice licensing laws.
<br>(3) Eligibility
<br>
<br>To be eligible to receive funds under paragraph (1), an entity shall—
<br>
<br>(A) prepare and submit to the State an application at such time, in such manner and containing such information as the State may require; and
<br>
<br>(B) be a public elementary or secondary school—
<br>
<br>(i) that is located in an urban area in which and 1 more than 50 percent of the student population is participating in Federal or State free or reduced meal programs; or
<br>
<br>(ii) that is located in a rural area and, with respect to the school district in which the school is located, the district involved has a median income that is at or below 235 percent of the poverty line, as defined in section 9902(2) of this title.
<br>(d) Oral health infrastructure
<br>(1) Cooperative agreements
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall enter into cooperative agreements with State, territorial, and Indian tribes or tribal organizations (as those terms are defined in section 1603 of title 25) to establish oral health leadership and program guidance, oral health data collection and interpretation,2 (including determinants of poor oral health among vulnerable populations), a multi-dimensional delivery system for oral health, and to implement science-based programs (including dental sealants and community water fluoridation) to improve oral health.
<br>(2) Authorization of appropriations
<br>
<br>There is authorized to be appropriated such sums as necessary to carry out this subsection for fiscal years 2010 through 2014.
<br>(e) Definitions
<br>
<br>For purposes of this section, the term "Indian tribe" means an Indian tribe or tribal organization as defined in section 5304(b) and section 5304(c) 3 of title 25.
<br>(f) Authorization of appropriations
<br>
<br>For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.
<br>
<br>(July 1, 1944, ch. 373, title III, §317M, as added Pub. L. 106–310, div. A, title XVI, §1602, Oct. 17, 2000, 114 Stat. 1148; amended Pub. L. 111–148, title IV, §4102(b), (c), Mar. 23, 2010, 124 Stat. 551, 552.)
<br>References in Text
<br>
<br>Section 5304 of title 25, referred to in subsec. (e), has been amended, and subsecs. (b) and (c) of section 5304 no longer define the terms "Indian tribe" and "tribal organization". However, such terms are defined elsewhere in that section.
<br>Amendments
<br>
<br>2010—Subsec. (c)(1). Pub. L. 111–148, §4102(b), substituted "shall award a grant to each of the 50 States and territories and to Indians, Indian tribes, tribal organizations and urban Indian organizations (as such terms are defined in section 1603 of title 25)" for "may award grants to States and Indian tribes".
<br>
<br>Subsecs. (d) to (f). Pub. L. 111–148, §4102(c), added subsec. (d) and redesignated former subsecs. (d) and (e) as (e) and (f), respectively.
<br>
<br>1 So in original. The word "and" probably should not appear.
<br>
<br>2 So in original. The comma probably should not appear.
<br>
<br>3 See References in Text note below.
<br>§247b–14a. Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment
<br>(a) In general
<br>
<br>The Secretary of Health and Human Services, through the Maternal and Child Health Bureau, the Indian Health Service, and in consultation with the National Institutes of Health and the Centers for Disease Control and Prevention, shall—
<br>
<br>(1) support community-based research that is designed to improve understanding of the etiology, pathogenesis, diagnosis, prevention, and treatment of pediatric oral, dental, craniofacial diseases and conditions and their sequelae in high risk populations;
<br>
<br>(2) support demonstrations of preventive interventions in high risk populations including nutrition, parenting, and feeding techniques; and
<br>
<br>(3) develop clinical approaches to assess individual patients for the risk of pediatric dental disease.
<br>(b) Compliance with State practice laws
<br>
<br>Treatment and other services shall be provided pursuant to this section by licensed dental health professionals in accordance with State practice and licensing laws.
<br>(c) Authorization of appropriations
<br>
<br>There are authorized to be appropriated such sums as may be necessary to carry out this section for each 1 the fiscal years 2001 through 2005.
<br>
<br>(Pub. L. 106–310, div. A, title XVI, §1601, Oct. 17, 2000, 114 Stat. 1148.)
<br>Codification
<br>
<br>Section was enacted as part of the Children's Health Act of 2000, and not as part of the Public Health Service Act which comprises this chapter.
<br>
<br>1 So in original. Probably should be followed by "of".
<br>§247b–15. Surveillance and education regarding infections associated with illicit drug use and other risk factors
<br>(a) In general
<br>
<br>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may (directly or through grants to public and nonprofit private entities) provide for programs for the following:
<br>
<br>(1) To cooperate with States and Indian tribes in implementing or maintaining a national system to determine the incidence of infections commonly associated with illicit drug use, such as viral hepatitis, human immunodeficiency virus, and infective endocarditis, and to assist the States in determining the prevalence of such infections, which may include the reporting of cases of such infections.
<br>
<br>(2) To identify, counsel, and offer testing to individuals who are at risk of infections described in paragraph (1) resulting from illicit drug use, receiving blood transfusions prior to July 1992, or other risk factors.
<br>
<br>(3) To provide appropriate referrals for counseling, testing, and medical treatment of individuals identified under paragraph (2) and to ensure, to the extent practicable, the provision of appropriate follow-up services.
<br>
<br><br><a href="Rules-1976.html">Next page</a> 
<a href="Rules-1974.html">Previous page</a>
<br><br><a href="index.html">Home</a>
